The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile

BMC Cardiovascular Disorders

Volumn 8, Issue , 2008, Pages

  Börgel, Jan ^a   Bulut, Daniel ^a   Hanefeld, Christoph ^a   Neubauer, Horst ^a   Mügge, Andreas ^a   Epplen, Jörg T ^b   Holland Letz, Tim ^b   Spiecker, Martin ^c  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2J2; GUANOSINE; THYMIDINE; ARACHIDONATE EPOXYGENASE; CYTOCHROME P450;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SLEEP APNEA SYNDROME; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GERMANY; HEART MUSCLE; MALE; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CYTOCHROME P-450 ENZYME SYSTEM; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 61549126887     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-8-41     Document Type: Article

References (17)

1. Wu SN Li HF Chiang HT Actions of epoxyeicosatrienoic acid on large-conductance Ca(2+)-activated K(+) channels in pituitary GH(3) cells Biochem Pharmacol 2000, 60:251-62. 10.1016/S0006-2952(00)00317-8 10825470
2. Node K Huo Y Ruan X Yang B Spiecker M Ley K Zeldin DC Liao JK Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 1999, 285:1276-9. 10.1126/science.285.5431.1276 10455056
3. Sun J Sui X Bradbury JA Zeldin DC Conte MS Liao JK Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids Circ Res 2002, 90:1020-7. 10.1161/ 01.RES.0000017727.35930.33 12016269
4. Collins T Cybulsky MI NF-kappaB: Pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001, 107:255-64. 199202 11160146 10.1172/JCI10373
5. Oltman CL Weintraub NL VanRollins M Dellsperger KC Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation Circ Res 1998, 83:932-9. 9797342
6. Pinto A Abraham NG Mullane KM Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway J Pharmacol Exp Ther 1987, 240: 856-63. 3104582
7. Fisslthaler B Popp R Kiss L Potente M Harder DR Fleming I Busse R Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 1999, 401:493-7. 10.1038/46816 10519554
8. Node K Ruan XL Dai J Yang SX Graham L Zeldin DC Liao JK Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids J Biol Chem 2001, 276:15983-9. 10.1074/jbc.M100439200 11279071
9. Spiecker M Darius H Hankeln T Soufi M Sattler AM Schaefer JR Node K Borgel J Mugge A Lindpaintner K et al Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 Circulation 2004, 110:2132-6. 10.1161/01.CIR.0000143832.91812.60 15466638
10. Hoffmann MM Bugert P Seelhorst U Wellnitz B Winkelmann BR Boehm BO März W The -50G>T Polymorphism in the Promoter of the CYP2J2 Gene in Coronary Heart Disease: The Ludwigshafen Risk and Cardiovascular Health Study Clinical Chemistry 2007, 53:539-540. 10.1373/ clinchem.2006.084756 17327508
11. Liu PY Li YH Chao TH Wu HL Lin LJ Tsai LM Chen JH Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction Atherosclerosis 2006, 195(1):199-206. 10.1016/j.atherosclerosis.2006.11.001 17126841
12. Borgel J Sanner BM Bittlinsky A Keskin F Bartels NK Buechner N Huesing A Rump LC Mugge A Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels Eur Respir J 2006, 27:121-7. 10.1183/09031936.06.00131304 16387944
13. Borgel J Sanner BM Keskin F Bittlinsky A Bartels NK Buchner N Huesing A Rump LC Mugge A Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs Am J Hypertens 2004, 17:1081-7. 10.1016/j.amjhyper.2004.06.026 15607612
14. Peppard PE Young T Palta M Skatrud J Prospective study of the association between sleep-disordered breathing and hypertension N Engl J Med 2000, 342:1378-84. 10.1056/NEJM200005113421901 10805822
15. Ip MS Lam B Ng MM Lam WK Tsang KW Lam KS Obstructive sleep apnea is independently associated with insulin resistance Am J Respir Crit Care Med 2002, 165:670-6. 11874812
16. Marin JM Carrizo SJ Vicente E Agusti AG Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study Lancet 2005, 365:1046-53. 15781100
17. Rissanen AM Familial occurrence of coronary heart disease: Effect of age at diagnosis Am J Cardiol 1979, 44:60-6. 10.1016/0002-9149(79)90251-0 453047